Therefore, in this work we report the fabrication of new label-free impedimetric immunosensors for the detection of IKZF1 and IKZF3 at the femtomolar levels for MM patients given lenalidomide treatment. The gene discussed is IKZF3; the disease is Miyoshi myopathy.